目的观察弗隆和氨鲁米特治疗绝经后晚期乳腺癌的疗效和不良反应。
Objective: to compare the response and adverse reactions of aminoglutethimide with that of femara, an oral aromatase inhibitor, in postmenopausal women with advanced breast cancer.
目的观察弗隆和氨鲁米特治疗绝经后晚期乳腺癌的疗效和不良反应。
Objective: to compare the response and adverse reactions of aminoglutethimide with that of femara, an oral aromatase inhibitor, in postmenopausal women with advanced breast cancer.
应用推荐